Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), and the Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organization specializing in the advancement of the cell and gene therapy industry, have joined forces to demonstrate universal automation of CGT manufacturing.   The partnership will integrate existing bioprocessing equipment at the CGT Catapult’s Stevenage Manu...